Biomarck’s MARCKS Inhibitors for Uveitis to be Presented at the 2021 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)

NEWTOWN, Pa.--(BUSINESS WIRE)-- #cytokinestorm--Biomarck's MARCKS inhibitors for uveitis will be presented at the 2021 Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO).